Clinical Trial Detail

NCT ID NCT03450109
Title A Study to Assess LY01005 Versus Goserelin Comparator (ZOLADEX) in Patients With Prostate Cancer
Recruitment Completed
Gender male
Phase Phase I
Variant Requirements No
Sponsors Luye Pharma Group Ltd.
Indications

prostate cancer

Therapies

LY01005

Goserelin

Age Groups: adult senior

No variant requirements are available.